The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Major Depressive DisorderInflammationCognitive DysfunctionEndotoxemiaGenetic Predisposition to DiseaseBlood Brain Barrier Defect
Interventions
DIAGNOSTIC_TEST

The Cambridge Neuropsychological Test Automated Battery.

to determine cognitive dysfunction

DIAGNOSTIC_TEST

Venous blood samples

to measure levels of cytokines, endotoxin, and genetic markers.

DIAGNOSTIC_TEST

brain MRI

to evaluate BBB permeability to water, brain structure volumes, white matter integrity, cerebral perfusion, and neurometabolite concentrations

DIAGNOSTIC_TEST

the Montgomery-Åsberg Depression Rating Scale

to measure severity of depressive symptoms

OTHER

questionnaire prepared by the researchers

collecting sociodemographic data and information about smoking status, BMI, data on the course of MDD, past treatment, comorbid diseases, and current use of medications.

Trial Locations (2)

50161

RECRUITING

Psychiatry Department, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas

Unknown

RECRUITING

Psychiatry Department, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas

All Listed Sponsors
lead

Lithuanian University of Health Sciences

OTHER